Created: 2022-01-27T01:12:16-06:00
This card pertains to a resource available on the internet.
BMJ 10.1136/bmj.n2635
Brook Jason notified Ventavia of failures in quality control and was fired after notifying the FDA.
Needles were not disposed of correctly.
Information was left on documents which allowed staff to violate the blinding of the study.
Management knew of data falsification occuring.
FDA refused to investigate Ventavia and later admitted it did not only checking 9 of 153 testing sites.